Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Indorama Ventures PCLINDOY +2.14%72 Days Sales Outstanding is 31.53 as of Jun. 2026, which is 14% below its 10-year median of 36.58. GuruFocus rates INDOY with a GF Score™ of 72/100 and a GF Value™ of $6.48 (Fairly Valued). The stock has 11 warning signs investors should review. Among 1,581 Chemicals companies, Indorama Ventures PCL ranks better than 81.91% on this metric.
Indorama Ventures PCL (OTCPK:INDOY) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
Indorama Ventures PCL Days Sales Outstanding Related Terms
Indorama Ventures PCL Days Sales Outstanding Historical Data
* Premium members only.
The historical data trend for Indorama Ventures PCL's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Indorama Ventures PCL Days Sales Outstanding Chart
For the Chemicals subindustry, Indorama Ventures PCL's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Indorama Ventures PCL Days Sales Outstanding vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Indorama Ventures PCL's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where Indorama Ventures PCL's Days Sales Outstanding falls into.
Indorama Ventures PCL Days Sales Outstanding Calculation
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Indorama Ventures PCL (INDOY) has a Days Sales Outstanding of 31.53 as of Jun. 2026. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Indorama Ventures PCL and its competitors. This is 14% below median its historical median of 36.58. Over the past decade, Indorama Ventures PCL's Days Sales Outstanding has ranged from 30.24 to 41.99. According to the industry distribution chart, Indorama Ventures PCL ranks #286 out of 1581 companies in the Chemicals industry, placing it in the top 18.1%.
Is Indorama Ventures PCL's Days Sales Outstanding too high?
Indorama Ventures PCL's current Days Sales Outstanding of 31.53 is 14% below median its 10-year median of 36.58. Over the past 10 years, this metric has ranged from a low of 30.24 to a high of 41.99. The Chemicals industry median Days Sales Outstanding is 63.36. Indorama Ventures PCL's value of 31.53 is 50.2% below this industry median. Based on the distribution chart, Indorama Ventures PCL ranks #286 out of 1581 companies in the Chemicals industry, which is in the top quartile — a strong position relative to peers. Overall, Indorama Ventures PCL has a GF Score™ of 72/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Indorama Ventures PCL's Days Sales Outstanding compare to DOW?
According to the Chemicals industry distribution chart, Indorama Ventures PCL ranks #286 out of 1581 companies for Days Sales Outstanding. This places Indorama Ventures PCL in the top 18% of its industry — outperforming the majority of peers. The industry median Days Sales Outstanding is 63.36. Indorama Ventures PCL's value of 31.53 is 50.2% below this benchmark. Historically, Indorama Ventures PCL's own Days Sales Outstanding has ranged from 30.24 to 41.99 over the past decade. While the company's 10-year median is 36.58 vs. the industry median of 63.36, Indorama Ventures PCL has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Sales Outstanding for a Chemicals company?
The median Days Sales Outstanding among Chemicals companies is 63.36, based on 1,581 companies in the industry. Companies in the top quartile (top 25%) have a Days Sales Outstanding significantly above this median, while those in the bottom quartile fall well below. However, Days Sales Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Indorama Ventures PCL's current Days Sales Outstanding of 31.53 is 50.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Sales Outstanding mean?
A high Days Sales Outstanding can signal that a stock is expensive relative to its fundamentals. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Indorama Ventures PCL and its competitors. For the Chemicals industry, the median Days Sales Outstanding is 63.36 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Indorama Ventures PCL's current Days Sales Outstanding is 31.53, which is 14% below median its own 10-year median of 36.58. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Indorama Ventures PCL stock overvalued right now?
Based on GuruFocus' analysis, Indorama Ventures PCL (INDOY) is currently considered Fairly Valued. The stock's GF Value™ is $6.48, compared to a current price of $6.69 — trading 3.2% above its estimated fair value. The current Days Sales Outstanding is 31.53, which is 14% below median its 10-year median of 36.58 and 50.2% below the Chemicals industry median of 63.36. Indorama Ventures PCL's overall GF Score™ is 72/100 with 11 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Sales Outstanding calculated?
Days Sales Outstanding is calculated from a company's financial statements. For Indorama Ventures PCL (INDOY), the current Days Sales Outstanding is 31.53 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Indorama Ventures PCL (INDOY) Overvalued in 2026?
Based on GuruFocus' analysis, Indorama Ventures PCL stock appears to be overvalued.
The current stock price of $6.69 is trading 3.2% above its estimated GF Value™ of $6.48.
GuruFocus considers Indorama Ventures PCL to be Fairly Valued.
Key valuation signals for INDOY:
Days Sales Outstanding: 31.53 (14% below median its 10-year median of 36.58)
GF Value™: $6.48 vs. price of $6.69 (3.2% above fair value)
Industry Position: 50.2% below the Chemicals median (#286 of 1581)
No single metric tells the full story. See the INDOY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Indorama Ventures PCL is engaged in the manufacture and distribution of Polyethylene Terephthalate, Purified Terephthalic Acid, Paraxylene, recycling, Purified Isophthalic Acid, Naphthalene Dicarboxylate, PET preforms and packaging, Integrated EG, Integrated purified EO, PO/MTBE, Integrated Surfactants comprising EOA, LAB and others, Fibers including Polyester, Rayon, Nylon, Polypropylene, composites and worsted wool fibers products. The company operates in three reportable segments Combined PET, Integrated Oxides and Derivatives and Fibers. The maximum revenue is derived from the Combined PET segment.
72GF Score
Get the complete analysis for INDOY
Days Sales Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
INDOY has been successfully added to your 
